Summary: MPM BioImpact sells entire stake in MBX Biosciences, reducing exposure by $14.8 million. MBX Biosciences operates a…
Biotech company MBX Biosciences saw a major specialist fund, MPM BioImpact, sell off its entire stake in the…
Sign in to your account